Carl Icahn Seeks To Remove Some Imclone Systems (IMCL) Directors
More News related to IMCL
- Top 15 For 2008 (No. 14): M&A Wreckage
- NASDAQ OMX and Leerink Swann to Co-Host Healthcare Industry Forum
- Lilly Completes Cash Tender Offer for ImClone Systems
- ImClone Systems' State-of-the-Art Manufacturing Facility Receives FDA Approval for Multi-Product Biologics Production
- Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
In an amended 13D filing on Imclone Systems Inc. (Nasdaq: IMCL), 13.85% holder Carl Icahn said he intends to solicit consents from stockholders of the company to remove certain directors from the Board of the Issuer and to fill one of the vacancies with a nominee to be proposed by Mr. Icahn and his affiliates, and, in connection therewith, today filed a preliminary consent solicitation statement with the Securities and Exchange Commission, which statement may be amended prior to its use and is not yet in definitive form.
Related Categories
13DsManagement Changes
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
